|
【结 构 式】 
|
【药物名称】 【化学名称】6-(2,6-Difluorobenzyl)-5-methyl-2-(methylsulfanyl)pyrimidin-4(3H)-one 【CA登记号】 【 分 子 式 】C13H12F2N2OS 【 分 子 量 】282.31419 |
【开发单位】 【药理作用】 |
合成路线1
The condensation of 2-(2,6-difluorophenyl)acetic acid (I) with 2-methylmalonic acid monoethyl ester sodium salt (II) gives 4-(2,6-difluorophenyl)-2-methyl-3-oxobutyric acid ethyl ester (III), which is cyclized with thiourea (IV) to yield 6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one (V). Finally this compound is reacted with methyl chloride by means of K2CO3 to afford the target pyrimidinone.
| 【1】 Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 51809 | 2,6-Difluorophenylacetic acid | 85068-28-6 | C8H6F2O2 | 详情 | 详情 |
| (II) | 51813 | potassium 3-ethoxy-2-methyl-3-oxopropanoate | C6H9KO4 | 详情 | 详情 | |
| (III) | 51814 | ethyl 4-(2,6-difluorophenyl)-2-methyl-3-oxobutanoate | C13H14F2O3 | 详情 | 详情 | |
| (IV) | 10180 | Thiourea | 62-56-6 | CH4N2S | 详情 | 详情 |
| (V) | 51815 | 6-(2,6-difluorobenzyl)-5-methyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone | C12H10F2N2OS | 详情 | 详情 |
Extended Information